OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Base editing of haematopoietic stem cells rescues sickle cell disease in mice
Gregory A. Newby, Jonathan Yen, Kaitly J. Woodard, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 295-302
Open Access | Times Cited: 276
Gregory A. Newby, Jonathan Yen, Kaitly J. Woodard, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 295-302
Open Access | Times Cited: 276
Showing 1-25 of 276 citing articles:
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
Samagya Banskota, Aditya Raguram, Susie Suh, et al.
Cell (2022) Vol. 185, Iss. 2, pp. 250-265.e16
Open Access | Times Cited: 403
Samagya Banskota, Aditya Raguram, Susie Suh, et al.
Cell (2022) Vol. 185, Iss. 2, pp. 250-265.e16
Open Access | Times Cited: 403
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 296
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 296
Therapeutic in vivo delivery of gene editing agents
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 285
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 285
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
Siwei Wang, Chao Gao, Yi-Min Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 254
Siwei Wang, Chao Gao, Yi-Min Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 254
CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 151
Tarun S. Nambiar, Lou Baudrier, Pierre Billon, et al.
Molecular Cell (2022) Vol. 82, Iss. 2, pp. 348-388
Open Access | Times Cited: 151
In vivo hematopoietic stem cell modification by mRNA delivery
Laura Breda, Tyler E. Papp, Michael Triebwasser, et al.
Science (2023) Vol. 381, Iss. 6656, pp. 436-443
Open Access | Times Cited: 151
Laura Breda, Tyler E. Papp, Michael Triebwasser, et al.
Science (2023) Vol. 381, Iss. 6656, pp. 436-443
Open Access | Times Cited: 151
In vivo somatic cell base editing and prime editing
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 112
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 112
Engineering a precise adenine base editor with minimal bystander editing
Liang Chen, Shun Zhang, Niannian Xue, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 1, pp. 101-110
Closed Access | Times Cited: 103
Liang Chen, Shun Zhang, Niannian Xue, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 1, pp. 101-110
Closed Access | Times Cited: 103
Genotoxic effects of base and prime editing in human hematopoietic stem cells
Martina Fiumara, Samuele Ferrari, Attya Omer, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 6, pp. 877-891
Open Access | Times Cited: 91
Martina Fiumara, Samuele Ferrari, Attya Omer, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 6, pp. 877-891
Open Access | Times Cited: 91
In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles
Dennis Shi, Shou Toyonaga, Daniel G. Anderson
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2938-2944
Open Access | Times Cited: 82
Dennis Shi, Shou Toyonaga, Daniel G. Anderson
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2938-2944
Open Access | Times Cited: 82
Designing and executing prime editing experiments in mammalian cells
Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, et al.
Nature Protocols (2022) Vol. 17, Iss. 11, pp. 2431-2468
Open Access | Times Cited: 81
Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, et al.
Nature Protocols (2022) Vol. 17, Iss. 11, pp. 2431-2468
Open Access | Times Cited: 81
Massively parallel base editing to map variant effects in human hematopoiesis
Jorge D. Martin-Rufino, Nicole Castano, Michael Pang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2456-2474.e24
Open Access | Times Cited: 77
Jorge D. Martin-Rufino, Nicole Castano, Michael Pang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2456-2474.e24
Open Access | Times Cited: 77
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
Kelcee A. Everette, Gregory A. Newby, Rachel M. Levine, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 5, pp. 616-628
Open Access | Times Cited: 71
Kelcee A. Everette, Gregory A. Newby, Rachel M. Levine, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 5, pp. 616-628
Open Access | Times Cited: 71
Human genetic diversity alters off-target outcomes of therapeutic gene editing
Samuele Cancellieri, Jing Zeng, Linda Yingqi Lin, et al.
Nature Genetics (2022) Vol. 55, Iss. 1, pp. 34-43
Open Access | Times Cited: 69
Samuele Cancellieri, Jing Zeng, Linda Yingqi Lin, et al.
Nature Genetics (2022) Vol. 55, Iss. 1, pp. 34-43
Open Access | Times Cited: 69
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
Frédéric B. Piel, David C. Rees, Michael R. DeBaun, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e633-e686
Open Access | Times Cited: 64
Frédéric B. Piel, David C. Rees, Michael R. DeBaun, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e633-e686
Open Access | Times Cited: 64
Successes and challenges in clinical gene therapy
Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer
Gene Therapy (2023) Vol. 30, Iss. 10-11, pp. 738-746
Open Access | Times Cited: 60
Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer
Gene Therapy (2023) Vol. 30, Iss. 10-11, pp. 738-746
Open Access | Times Cited: 60
Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing
Grace E. McAuley, Gloria Yiu, Patrick Chang, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1398-1416.e23
Open Access | Times Cited: 54
Grace E. McAuley, Gloria Yiu, Patrick Chang, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1398-1416.e23
Open Access | Times Cited: 54
Therapeutic adenine base editing of human hematopoietic stem cells
Jiaoyang Liao, Shuanghong Chen, Shenlin Hsiao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Jiaoyang Liao, Shuanghong Chen, Shenlin Hsiao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Light‐Guided Genetic Scissors Based on Phosphorene Quantum Dot
Zhi Chen, Hao Huang, Jiefeng Deng, et al.
Laser & Photonics Review (2024) Vol. 18, Iss. 11
Closed Access | Times Cited: 29
Zhi Chen, Hao Huang, Jiefeng Deng, et al.
Laser & Photonics Review (2024) Vol. 18, Iss. 11
Closed Access | Times Cited: 29
Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells
Xizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1409-1417
Closed Access | Times Cited: 28
Xizhen Lian, Sumanta Chatterjee, Yehui Sun, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 9, pp. 1409-1417
Closed Access | Times Cited: 28
Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA
Sung-Ik Cho, Kayeong Lim, Seongho Hong, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 95-109.e26
Open Access | Times Cited: 20
Sung-Ik Cho, Kayeong Lim, Seongho Hong, et al.
Cell (2024) Vol. 187, Iss. 1, pp. 95-109.e26
Open Access | Times Cited: 20
Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells
Alexander A. Sousa, Colin Hemez, Lei Lei, et al.
Nature Biomedical Engineering (2024)
Open Access | Times Cited: 19
Alexander A. Sousa, Colin Hemez, Lei Lei, et al.
Nature Biomedical Engineering (2024)
Open Access | Times Cited: 19
Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments
Marine Laurent, Marine Geoffroy, Giulia Pavani, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 800-800
Open Access | Times Cited: 15
Marine Laurent, Marine Geoffroy, Giulia Pavani, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 800-800
Open Access | Times Cited: 15
